Program
IMG-007
A development code.
Its studies are mostly in Dermatitis, Atopic · Alopecia Areata, led by Inmagene.
Furthest: phase 2, since Jul 25, 20235 company-led studies, 2 open or runningNext primary completion: Dec 2027 (phase 2)
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Inmagene | 52 open or running | phase 2since Jul 25, 2023 | Jul 25, 2023 | Dec 2027phase 2 · NCT07037901 |
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jul 25, 2023First study: phase 2 study in Dermatitis, AtopicFirst studyNCT05984784 · 13 enrolled · United States, Canada
- Sep 21, 2023Phase 2 study in Alopecia AreataNCT06060977 · 29 enrolled · United States, Canada
- Mar 3, 2024Phase 1 study in Healthy VolunteersNCT06304740 · 16 enrolled · Australia
- Jun 17, 2025Phase 2 study in Dermatitis, AtopicNCT07037901 · 405 planned · United States, Australia, Canada and more
- Jun 11, 2026Phase 2 study in Dermatitis, AtopicNCT07734415 · 400 planned · United States, Canada
Ahead
- Dec 2027Primary completion: phase 2 study in Dermatitis, AtopicNCT07037901
- Mar 2028Primary completion: phase 2 study in Dermatitis, AtopicNCT07734415
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 5 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07734415Dermatitis, Atopic · United States, Canada | 2 | By invitation | Mar 2028 | 400 |
| NCT07037901Dermatitis, Atopic · United States, Australia, Canada and more | 2 | Recruiting | Dec 2027 | 405 |
| NCT06304740Healthy Volunteers · Australia | 1 | Terminated | Aug 28, 2024 | 16 |
| NCT06060977Alopecia Areata · United States, Canada | 2 | Completed | Jan 14, 2025 | 29 |
| NCT05984784Dermatitis, Atopic · United States, Canada | 2 | Terminated | Apr 26, 2024 | 13 |
How it is read
Names in the registry
- “IMG-007”, 5 entries
Codes read as this program: IMG007.
Conditions, from the studies’ own filings
- Dermatitis, Atopic, 3 studies
- Alopecia Areata, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.